Drug intelligence / Profile preview

Shenshao Capsules

Development stage: Unknown
Lead developer: Buchang Pharmaceutical Group
Administration: Oral

Overview

Shenshao Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated as a capsule and is primarily indicated for the treatment of cardiovascular and cerebrovascular diseases, including coronary heart disease and angina pectoris. The medicine is based on the therapeutic principles of invigorating Qi and activating blood circulation to resolve stasis, typically containing extracts from *Panax ginseng* (Ginseng) and *Paeonia lactiflora* (White Peony Root). It is used to improve symptoms such as chest pain, palpitations, and shortness of breath associated with Qi deficiency and blood stasis.

Brand names: Shenshao Capsules
Other names: Shenshao Jiaonang参芍胶囊

Beyond the preview

Go deeper on Shenshao Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenshao Capsules.

Explore the full profile